Position history for Capital Research Global Investors's holdings in TAKEDA PHARMACEUTICAL
Capital Research Global Investors holds 19.1M shares of TAK (TAKEDA PHARMACEUTICAL), worth $353.8M as of 2026-Q1. The position was increased (+41.6% shares). TAK represents 0.1% of Capital Research Global Investors's portfolio.
Current Value
$353.8M
Current Shares
19.1M
Total Value Change
+$184M
Total Shares Change
+6M
Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, ARK Investment Management LLC
Increased |
| 19.1M |
+41.6% |
| $353.8M |
| 0.1% |
| $18.08 |
41 |
| 2025-Q4 | Increased | 13.5M | +0.6% | $210.3M | 0.0% | $15.63 | 31 |
| 2025-Q3 | Increased | 13.4M | +0.8% | $196.2M | 0.0% | $14.62 | 31 |
| 2025-Q2 | Increased | 13.3M | +0.7% | $205.5M | 0.0% | $15.10 | 31 |
| 2025-Q1 | Increased | 13.2M | +0.3% | $196.3M | 0.0% | $14.71 | 31 |
| 2024-Q4 | Increased | 13.2M | +0.2% | $174.3M | 0.0% | $12.87 | 30 |
| 2024-Q3 | Increased | 13.1M | +0.1% | $186.8M | 0.0% | $13.89 | 30 |
| 2024-Q2 | Increased | 13.1M | +0.0% | $169.9M | 0.0% | $12.36 | 30 |